Business News • MarketWire • Radient Pharmaceuticals Announces Formation of New Subsidiary NuVax Therapeutics Inc. |
Radient Pharmaceuticals Announces Formation of New Subsidiary NuVax Therapeutics Inc. |
|
|
Radient Pharmaceuticals Announces Formation of New Subsidiary NuVax Therapeutics Inc.
TUSTIN, CA--(Marketwire - December 7, 2010) - Radient Pharmaceuticals Corporation (RPC) (NYSE Amex: RPC) in partnership with Jaiva Technologies, today announced the formation of NuVax Therapeutics, Inc. ("NuVax") -- a wholly owned subsidiary of Radient Pharmaceuticals. The formation of NuVax Therapeutics is a strategic move on the part of RPC to enhance the Company's Q2 2010 collaboration agreement with U.S.-based Jaiva Technologies -- a biotechnology company focused on the research and development, distribution, marketing and sales of promising third-party healthcare technology products.
View More : http://www.marketwire.com/mw/release.do?id=1365000&sourceType=3
|
|
|